meditab irinotecan irinotecan hydrochloride trihydrate 40 mg / 2 ml injection vial
cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: sodium hydroxide; water for injections; lactic acid; sorbitol - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.
meditab irinotecan irinotecan hydrochloride trihydrate 100 mg / 5 ml injection vial
cipla australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection - excipient ingredients: sorbitol; lactic acid; water for injections; sodium hydroxide - as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.
granisetron 1mg tablets
apc pharmaceuticals & chemicals (europe) ltd - granisetron hydrochloride - oral tablet - 1mg
setonix solution for injection
ms pharma jordan king abdulla (ii) bin al-hussein industrial - granisetron hydrochloride ep - solution for injection - each ml contains: granisetron hydrochloride bp - granisetron
kytril 1 mg/1 ml solution for injection
atnahs pharma netherlands b.v. - granisetron hydrochloride - solution for injection - 1 milligram(s)/millilitre - serotonin (5ht3) antagonists; granisetron
kytril 3 mg/3 ml solution for injection
atnahs pharma netherlands b.v. - granisetron hydrochloride - solution for injection - 3 milligram(s)/millilitre - serotonin (5ht3) antagonists; granisetron
granisetron b. braun 1 mg/ml solution for injection
b. braun melsungen ag - granisetron hydrochloride granisetron - solution for injection - 1 mg/ml
camptosar irinotecan hydrochloride trihydrate 300mg/15ml injection vial
pfizer australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: sorbitol; hydrochloric acid; water for injections; sodium hydroxide; lactic acid - camptosar is indicated as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum and is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.
granisetron 2mg tablets
viatris uk healthcare ltd - granisetron hydrochloride - oral tablet - 2mg
granisetron 2mg tablets
a a h pharmaceuticals ltd - granisetron hydrochloride - oral tablet - 2mg